JG
John Gerecitano
Medical Oncology
Credentials: ·
History
Medical Oncology
Internal Medicine
Research
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2016 · 1,585 citations
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Nature Medicine · 2015 · 979 citations
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2018 · 784 citations
- AZ
20 papers
- PH
20 papers
19 papers
- DS
18 papers
- AN
17 papers
- AY
16 papers
16 papers
- CP
15 papers
